GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Days Sales Outstanding

IVD Medical Holding (HKSE:01931) Days Sales Outstanding : 54.57 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Days Sales Outstanding?

IVD Medical Holding's average Accounts Receivable for the six months ended in Dec. 2023 was HK$560 Mil. IVD Medical Holding's Revenue for the six months ended in Dec. 2023 was HK$1,872 Mil. Hence, IVD Medical Holding's Days Sales Outstanding for the six months ended in Dec. 2023 was 54.57.

The historical rank and industry rank for IVD Medical Holding's Days Sales Outstanding or its related term are showing as below:

HKSE:01931' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.51   Med: 71.48   Max: 129.68
Current: 63.11

During the past 8 years, IVD Medical Holding's highest Days Sales Outstanding was 129.68. The lowest was 43.51. And the median was 71.48.

HKSE:01931's Days Sales Outstanding is ranked better than
59.57% of 94 companies
in the Medical Distribution industry
Industry Median: 73.455 vs HKSE:01931: 63.11

IVD Medical Holding's Days Sales Outstanding declined from Dec. 2022 (60.22) to Dec. 2023 (54.57).


IVD Medical Holding Days Sales Outstanding Historical Data

The historical data trend for IVD Medical Holding's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Days Sales Outstanding Chart

IVD Medical Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 43.51 59.51 63.95 77.31 65.64

IVD Medical Holding Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.49 78.95 60.22 70.87 54.57

Competitive Comparison of IVD Medical Holding's Days Sales Outstanding

For the Medical Distribution subindustry, IVD Medical Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IVD Medical Holding's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, IVD Medical Holding's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where IVD Medical Holding's Days Sales Outstanding falls into.



IVD Medical Holding Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

IVD Medical Holding's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (632.949 + 582.063) / 2 ) / 3378.012*365
=607.506 / 3378.012*365
=65.64

IVD Medical Holding's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (537.086 + 582.063) / 2 ) / 1871.536*365 / 2
=559.5745 / 1871.536*365 / 2
=54.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IVD Medical Holding  (HKSE:01931) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


IVD Medical Holding Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


IVD Medical Holding (HKSE:01931) Business Description

Traded in Other Exchanges
N/A
Address
Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN
IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.
Executives
Leung King Sun
Wu Meizhen 2201 Interest of corporation controlled by you
China International Trust Limited 2201 Interest of corporation controlled by you
Wu Yanfeng 2201 Interest of corporation controlled by you
Wu Mingcong 2201 Interest of corporation controlled by you
Wu Junfeng 2201 Interest of corporation controlled by you
Shen Li 2201 Interest of corporation controlled by you
Nd Medical Technology Limited 2201 Interest of corporation controlled by you
Ma Zhouwei 2201 Interest of corporation controlled by you
Hong Kong Medicine Group Limited 2201 Interest of corporation controlled by you
Hknd Gene Biotechnology Limited 2201 Interest of corporation controlled by you
Fast Benefit Pharmaceutical Limited 2201 Interest of corporation controlled by you
China Smart Pharmaceutical Technology Limited 2201 Interest of corporation controlled by you
3w.com Holding Limited 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you

IVD Medical Holding (HKSE:01931) Headlines

No Headlines